Greenzone Pharms

Greenzone Pharms

First CBD Hemp Processor in Illinois

First CBD Hemp Processor in Illinois

Overview

Raised to Date: Raised: $11,020

Total Commitments ($USD)

Platform

Fundanna

Start Date

02/18/2020

Close Date

11/30/2021

Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment

$200

Security Type

Revenue Share

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Return Multiple

3.00X

Rolling Commitments ($USD)

Status
Funded
Reporting Date

12/05/2021

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$17

# of Investors

45

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

1969

Industry

Alcohol, Tobacco, & Recreational Drugs

Tech Sector

Non-Tech

Distribution Model

B2B

Margin

Low

Capital Intensity

Low

Business Type

Life Style

Greenzone Pharms, with a pre-money valuation of $5 million, is raising funds on Fundanna Crowdfunding. The company is a licensed grower of hemp in Wisconsin and the first CBD hemp processor in Illinois. Greenzone Pharms uses techniques like cloning, genetics, and CO2 supercritical oil extraction to create CBD-infused products. Greenzone Pharms was founded by Dan Marlow and has Mike Gawinski as the facilities foreman. The current round of crowdfunding has a minimum goal of $10,000 and a maximum goal of $1,070,000, and the proceeds will be used towards marketing and advertising, inventory, equipment, staffing, and operating expenses. Greenzone Pharms is leading among its peers because of its high-quality formulations and beautiful packaging of CBD and hemp products.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$121,205

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$30,784

$-13,069

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$470

$0

Accounts Receivable

$13,835

$0

Total Assets

$246,048

$197,096

Short-Term Debt

$14,557

$5,469

Long-Term Debt

$0

$0

Total Liabilities

$14,557

$5,469

Financials as of: 02/18/2020
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Greenzone Pharms on Fundanna
Platform: Fundanna
Security Type: Revenue Share

Follow company

Follow Greenzone Pharms on Fundanna

Buy Greenzone Pharms's Deal Report

Warning: according to the close date for this deal, Greenzone Pharms may no longer be accepting investments.

Greenzone Pharms Deal Report

Get KingsCrowd’s comprehensive report on Greenzone Pharms including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Greenzone Pharms is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Greenzone Pharms deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge